Real‐Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology 2026 Open access

Read full text
Authors: Eugenia Veronica Di Brizzi, Stefano Caccavale, Graziella Babino, Rocco De Pasquale, Valeria Falcomatà, Claudia Giofrè, Giampiero Mazzocchetti, Pietro Morrone, Giovanni Palazzo, A. Balato
DOI: 10.1111/ijd.70263
Cited by: 1
References: 5

Abstract

Valeria Falcomatà has conflicts of interest with AbbVie and Johnson&Johnson. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Fields of Study & Subjects

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Urticaria and Related Conditions

Publication details

Journal / source
International Journal of Dermatology
Publisher
Wiley
Volume
65
Issue
6
Pages
1282–1284
Publication date
13 January 2026
Language
EN